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STUDY PROTOCOL Open Access
The effect of targeted exercise on knee-
muscle function in patients with persistent
hamstring deficiency following ACL
reconstruction – study protocol for a
randomized controlled trial
Bo Bregenhof1,3* , Uffe Jørgensen1, Per Aagaard2, Nis Nissen3, Mark W. Creaby4, Jonas Bloch Thorlund2,
Carsten Jensen3, Trine Torfing5 and Anders Holsgaard-Larsen1
Abstract
Background: Anterior cruciate ligament (ACL) reconstruction, using hamstring auto-graft is a common surgical
procedure, which often leads to persistent hamstring muscle-strength deficiency and reduced function. The purpose of
this randomized controlled trial (RCT) is to investigate the effect of a combined, progressive, strength and neuromuscular
exercise intervention on knee muscle strength, functional capacity and hamstring muscle-tendon morphology in
ACL-reconstructed patients with persistent hamstring muscle-strength deficiency compared with controls.
Methods/design: The study is designed as a multicenter, parallel-group RCT with balanced randomization (1:1) and
blinded outcome assessments (level of evidence: II) and will be reported in accordance with the CONSORT Statement.
Fifty ACL-reconstructed patients (hamstring auto-graft) with persistent limb-to-limb knee-flexor muscle-strength
asymmetry at 12–24 months’ post surgery, will be recruited through outpatient clinics and advertisements. Patients will
be randomized to a 12-week progressive, strength and neuromuscular exercise group (SNG) with supervised training
twice weekly or a control intervention (CON) consisting of a home-based, low-intensity exercise program. Outcome
measures include between-group change in maximal isometric knee-flexor strength (primary outcome) and knee-extensor
muscle strength, hamstring-to-quadriceps strength ratios of the leg that has been operated on and Knee injury and
Osteoarthritis Outcome Score (KOOS) (secondary outcomes).
In addition, several explorative outcomes will be investigated: The International Knee Documentation Committee Subjective
Knee Form (IKDC), the Tegner Activity Score, rate of force development (RFD) for the knee flexors and extensors, tendon
regeneration and potential muscle hypertrophy at graft harvest site evaluated by magnetic resonance imaging (MRI),
postural control, kinetic/kinematic gait characteristics and knee-related functional capacity.
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Discussion: This RCT is designed to investigate the effect of combined, progressive-resistance and neuromuscular exercises
on knee-flexor/extensor strength, in the late rehabilitation phase following ACL reconstruction. Reduced hamstring strength
represents a potential risk factor for secondary ACL rupture and accelerated progression of osteoarthritis. If deemed
effective, the intervention paradigm introduced in this study may help to improve current treatment strategies in ACL-
reconstructed patients.
Trial registration: ClinicalTrials.gov, ID: NCT02939677 (recruiting). Registered on 20 October 2016.
Keywords: ACL reconstruction, Rehabilitation, Muscle strength, Physical function, Exercise,
Background
Anterior cruciate ligament (ACL) reconstruction is a com-
mon arthroscopic procedure, with approximately 300,000
reconstructions performed annually in the United States
[1]. ACL reconstruction aims to restore functional stability
of the knee, and can be performed using a variety of differ-
ent surgical techniques and graft sites [2]. The hamstring
tendon is one of the most commonly used graft donor sites
used for ACL reconstruction [1, 3]. Although current ACL
reconstruction procedures intend to restore internal knee
biomechanics, function of the ACL-reconstructed knee re-
mains different from that of healthy knees [4, 5] and is
associated with early development of osteoarthritis [6–8].
Therefore, information about factors associated with
increased risk of osteoarthritis, such as lower-limb muscle-
strength deficits, should be part of the risk management
with ACL reconstruction [6]. In a recent study, maximal
isometric hamstring-muscle strength was reported to be
22% lower in the ACL-reconstructed limb at 18 months
post surgery, and reduced knee-joint function was also
observed compared with healthy controls [9]. Notably,
hamstring muscles are considered important protagonists
to the ACL [10] and reduced knee-flexor strength repre-
sents a potential risk factor for secondary ACL rupture
[11]. According to international standards and consensus,
ACL postoperative rehabilitation is generally limited to the
first 9–12 months post surgery. Furthermore, the effect of
early (first 12 months post surgery) rehabilitation has pre-
viously been studied [12, 13] .Thus, long-term rehabilita-
tion protocols of ACL-reconstructed patients, especially
when using semitendinosus auto-grafts, are strongly
advised [14]. Due to well-documented positive effects,
neuromuscular training has become an integral part of
most early post-operative ACL reconstruction rehabilita-
tion programs [12, 15–17]. However, there is limited evi-
dence on studies performing muscle-strength interventions
during the late rehabilitation phase (12 months post sur-
gery) following ACL reconstruction [12, 14].
Tissue regeneration by means of magnetic resonance
imaging (MRI)-verified muscle volume and tendon-graft-
site regrowth is generally considered to be one of the piv-
otal preconditions for postoperative recovery in terms of
improved knee-joint function [18, 19]. Several studies have
examined the regenerative capacity of the semitendinosus
and gracilis tendons [20–22] demonstrating substantial
tendon regeneration at 6 months after time of harvesting.
However, regeneration is slow and may continue up to
approximately 12–24 months after ACL reconstruction,
without guarantee of full muscle-tendon regeneration
[20, 22], and thus it may have impact on the effect of
muscle-strength interventions.
The objective of this study is, therefore, to investigate the
effect of targeted exercise on knee-muscle strength and
joint function in ACL-reconstructed patients with persist-
ent hamstring muscle deficiency 12–24 months post sur-
gery compared with controls. Furthermore, an explorative
part of the study will evaluate the extent of tissue regener-
ation at the graft harvest site by MRI, and kinematic and
kinetic analyses on functional gait performances.
As such, this study is expected to provide important
clinical evidence on late-phase rehabilitation in ACL-
reconstructed patients. If deemed effective, these study
findings may help identify and refine optimal rehabilita-
tion paradigms for ACL-reconstructed patients and help
to describe and/or develop optimal exercise-based ther-
apy to improve donor-site tendon regeneration.
Methods/design
Study design
The study is designed as a prospective, superiority,
parallel-group randomized controlled trial (RCT) with
balanced and blinded randomization (1:1) with blinded
outcome assessment (level of evidence: II). The study
protocol adheres to the SPIRIT Statement (Standard
Protocol Items: Recommendations for Interventional
Trials) (see Additional file 1 for the SPIRIT Checklist
and Fig. 1 for the SPIRIT Figure) as well as to the CON-
SORT Statement (Consolidated Standards of Reporting
Trials) [23, 24].
Participants, randomization and blinding
A sample of 50 elective, ACL-reconstructed patients are
planned to be recruited at 12–24 months’ post-operative
outpatient clinic follow-up from the Department of Or-
thopaedics and Traumatology, Odense University Hos-
pital, Denmark and the Department of Orthopaedics,
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Lillebaelt Hospital, Kolding, Denmark, and from poster
advertisement at local sports clubs, education facilities,
etc.
Eligible patients (inclusion and exclusion criteria are
listed in Table 1) will receive verbal and written informa-
tion about the conditions of the trial and sign a stan-
dardized consent form. The primary investigator will
orally introduce the trial to eligible participants. Follow-
ing this, interested patients will receive written informa-
tion and an invitation to be screened using handheld
dynamometry for final evaluation of eligibility. Inclusion
criteria will be confirmed from the patient’s written
medical history, obtained from the surgeon, as well as
during conversation with the patient. Handheld dyna-
mometry will be used to determine objective eligibility
with respect to between-limb strength asymmetry.
Height and weight will be measured to determine Body
Mass Index (BMI). If participants meet the inclusion
criteria, they will be invited to participate in the study.
Written informed consent will be given prior to, or at,
baseline testing and collected by the primary investigator or
the study coordinator/study nurse. Finally, participants will
have the option of supplementary informed discussion with
the primary investigator at any time point prior to baseline
testing. Patients declining to participate in the trial will
receive standard healthcare instructions (specified below).
After baseline measurements, participants will be ran-
domly allocated (permuted blocks of four to six persons)
Fig. 1 SPIRIT Figure. Template of content for the schedule of enrollment, interventions and assessments
Table 1 Inclusion and exclusion criteria for participants in the
study
Inclusion Exclusion
• ACL reconstruction using
hamstring tendon auto-graft
• Other known joint pathology
that will affect participation in
the intervention
• Age between 18 and 40 years • BMI > 35
• A pathologically defined
between-limb asymmetry ratio
(> 10% leg-to-leg difference) for
maximal isometric strength of
the knee flexors at 12–24 months’
follow-up
• Decline to participate
• Not understanding written
Danish language
• Other known medical conditions
that will affect participation in the
intervention
ACL anterior cruciate ligament, BMI Body Mass Index
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to either the targeted exercise or the control group. The
randomization sequence will be computer generated using
Stata 13.0 (StataCorp, College Station, TX, USA) statistical
software with a 1:1 allocation ratio using sequentially
numbered opaque, sealed envelopes. The allocation
sequence and preparation of the concealed envelopes will
be completed by a central study coordinator (JL) not in-
volved in the conduct of the trial. To prevent bias during
the allocation sequence, the name and date of birth of the
participant will be written on the envelope immediately
after randomization by the research nurse. The primary
investigator will be blinded to allocation and will not par-
ticipate in testing, randomization or in the training of
study participants. The statistical analysis will be per-
formed on allocation codes only and thus the data analysts
will be blinded in relation to intervention allocation.
Blinding to treatment allocation of patients, physio-
therapists and nurses (healthcare providers) will not be
possible due to the nature of the interventions. However,
blinded, independent data collectors will be responsible
for baseline and follow-up assessments, and responses
entered in databases identified by identification numbers
only. The principal investigator and data analyst (BB)
will be blinded to treatment allocation as data will be
analyzed using coded identification numbers. The coding
and re-coding of the identification numbers will be
performed by the central study coordinator.
To maintain the overall quality and legitimacy of this
clinical trial, un-blinding in terms of allocation, will only
occur in exceptional circumstances (e.g., harm) when
knowledge of the actual treatment is essential for further
management of the participant. Investigators will before
un-blinding, discuss with the members of the projects
advisory group whether un-blinding is necessary and, to
which extent, the un-blinding unfolds. The primary
investigator will maintain the blind as far as possible.
Allocation will not be disclosed to other study personnel
including other site personnel, monitors, corporate
sponsors or project office staff. The investigator will
report all code breaks (with reason) as they occur.
Combined strength and neuromuscular exercise
intervention (SNG)
Participants allocated to combined muscle strengthening
and neuromuscular exercise (SNG) will be engaged in an
exercise regimen based on progressive strength training,
including elements of neuromuscular exercise. The train-
ing program is based on exercises described in the current
academic literature which have been applied to ACL-
reconstructed patients [16, 25–28] (Additional file 2).
Furthermore, advice on exercises from professional ex-
perts in physiotherapy, ACL-reconstruction rehabilitation
and knee-joint biomechanics, have been implemented. No
isolated development or feasibility work of the present
exercise program has been developed. Implementation in
accordance with “best practice” has been undertaken.
The SNG intervention will be performed twice weekly
for 12 weeks with each session lasting 60–70 min.
Patients will be admitted continuously into class-based
groups of both novice and experienced participants.
Group-based exercises will have a maximum of six par-
ticipants, and will be performed at the hospital rehabili-
tation facility (Kolding) as well as in a local commercial
fitness centre (Odense). The physiotherapists involved in
the training are experienced in the rehabilitation of
knee-related injuries, will participate in scientific semi-
nars on ACL-rehabilitation and exercise, and will be
instructed and trained in the specific intervention proto-
col by the principal investigator prior to the initiation of
participant recruitment.
After 2 weeks of familiarization with emphasis on correct
technique, the strengthening part of the intervention will
commence consisting of eight exercises (Additional file 2)
for the lower extremities performed in three sets of 10 rep-
etitions with an intensity of 12 repetitions maximum with
the time for rest (between sets). To apply with the princi-
ples of explosive-type resistance training (RFD-training)
the participants will be instructed to complete the concen-
tric phase of the movement “as fast as possible,” then pause
briefly, and complete the eccentric phase of the movement
in approximately 2–3 s. Measurements of the velocity
during the concentric phase are not applicable; however,
the quality of the explosive component of the exercise is
supervised by an experienced physiotherapist throughout
the entire intervention period. The participants are encour-
aged to perform the maximum number of repetitions
possible within each set. If the number of repetitions is
below 8 or exceeds 12, the loading will be adjusted for the
next set. The physiotherapists will supervise the individual
progression for each participant.
The neuromuscular aspects of the training program will
focus on proprioception and postural function with the key
elements being balance and functional stability [29]. To
allow for progression of the neuromuscular exercises, two
or three levels of difficulty are given (Additional file 2).
Progress is made when a given exercise is performed with
good sensorimotor control and a high quality of perform-
ance (based upon visual inspection by the physiotherapist).
Number of sets, reps and weight will be recorded to deter-
mine whether the patient is ready to progress after each
session. Acceptable compliance is defined as participation
in 75% or more of all training sessions (i.e., 18 sessions).
Control group (CON)
Controls (CON) will receive instructions (a pamphlet)
regarding a training regimen of home-based, weight-
bearing, low-intensity exercises (Additional file 3). CON
participants will be instructed and advised to perform
Bregenhof et al. Trials  (2018) 19:75 Page 4 of 13
the home-based exercises twice weekly. Specific exercise
instructions using body weight (gravity) and resistance
bands, will be provided by the physiotherapists upon
randomization (Additional file 3). The home-based
training regimen of the control group (CON) is based
upon the fact that persistent asymmetry of hamstring
muscle strength has been evaluated by hand-held dyna-
mometry, before enrollment. There is currently, no
established national guideline, concerning late rehabilita-
tion programs, to ACL patients with muscle asymmetry
and/or knee-instability symptoms. However, since the
referring surgeon has observed pathological asymmetry of
the knee-extensors at inclusion and for ethical reasons,
patients in the current trial are offered a low-resistance
exercise regimen to mimic realistic clinical guidelines for
the current patient group (Additional file 3).
Pain monitoring during exercise intervention
The intervention procedures may provoke musculoskel-
etal pain and participants will, therefore, be asked to rate
perceived pain intensity in their training diary before
and after training and test sessions using a Visual
Analogue Scale (VAS, 0 mm = no pain, 100 mm =worst
possible pain). Pain (muscle or joint) up to a level of
50 mm will be considered “acceptable” in the period
immediately after each training session. The day after
training, pain should subside to “pain as usual” and not
increase over time. “Pain as usual” is defined as the pain
level prior to exercise. If this does not occur, the level of
exercise progression will be reduced [25].
Participants in the CON group will have access
(phone) to the involved staff for advice throughout the
duration of the trial.
All loads (kg) lifted during all exercises will be re-
corded in an exercise diary, comprising the date of each
session (to determine the number of sessions), exercises
performed (including loads lifted, number of repetitions
and sets), perceived exertion (Borg RPE CR-10) [30].
Furthermore, SNG participants will be instructed to note
the individual resistance and level of difficulty for the
neuromuscular exercises (to determine progression).
During the study, no concomitant care or interventions
are prohibited.
Timing of assessments
Assessments will be performed at baseline (prior to
randomization), following the intervention (12 weeks
post baseline) (the primary endpoint) and 6 months post
intervention (Fig. 2; Table 2: Outcome measurements).
Subjects will be evaluated in terms of full range of
motion, and knee laxity, though proprioceptive status is
not evaluated before inclusion. Although testing for
quadriceps-muscle-strength deficit is part of the study,
eligible participants having only quadriceps muscle-
Table 2 Outcome measurements
Data collection instrument Collection time point
Baseline Post (12 weeks)
Primary endpoint
Post (6 months)
Primary outcome
Maximal isometric knee flexor strength
(of the ACL-reconstructed leg)
Maximal isometric dynamometry x x x
Secondary outcomes
KOOS – 5 subscales PROM x x x
Maximal isometric knee-extensor strength Maximal isometric dynamometry x x x
Hamstring-to-quadriceps ratio Maximal isometric dynamometry x x x
Explorative outcomes
Counter movement jump 3-dimensional motion analysis x x
Gait analysis 3-dimensional motion analysis x x
One-legged jump for distance Simple functional test x x
Postural sway Simple functional test x x
Rate of force development Maximal isometric dynamometry x x x
Quadriceps and hamstring morphologies
Volume
Peak cross-sectional area
Length
MRI x x
IKDC PROM x x x
Patient characteristics (age, BMI, time since operation, Tegner Activity Level Scale score) will be obtained at baseline
KOOS Knee injury and Osteoarthritis Outcome Score, IKDC International Knee Documentation Committee Subjective Knee Form, MRI magnetic resonance imaging,
PROM Patient-reported Outcome Measure
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strength deficits will not be included. After the interven-
tion period, all participants will be encouraged to
continue the exercise program unsupervised at home or
in their local fitness center.
Patient characteristics
At baseline (prior to randomization), height and weight
will be measured, and age will be recorded. Time since
surgery will be obtained from the Danish National ACL
Reconstruction Registry and the Tegner Activity Level
Scale will be completed.
Primary outcome measure
The primary outcome is the between-group change in
maximal unilateral isometric knee-flexor strength (ham-
string) recorded in the leg that has been operated on
using stabilized dynamometry at a 90° angle (0° = full
anatomical extension), according to methods described
by Jensen et al. [31] and Holsgaard-Larsen et al. [9]. In
general, excellent test-retest reliability in lower-limb
muscle strength has been reported in both healthy
people and patients [32, 33].
Secondary outcome measures
Between-group changes in maximal unilateral isometric
extensor strength (quadriceps) and hamstring-to-
quadriceps-muscle-strength ratio will be obtained using
the same type of stabilized dynamometry as used for the
primary outcome variable [9, 32, 34, 35]. Furthermore,
the Knee injury and Osteoarthritis Outcome Score
(KOOS) questionnaire will be administered to all trial
participants to assess their perception of daily knee func-
tion and related symptoms [36, 37]. KOOS is a 42-item,
self-administered, self-explanatory questionnaire that
covers five patient-relevant categories: Pain, Other
Disease-Specific Symptoms, Activity of Daily Living
Function, Sport and Recreation Function and Knee-
related quality of life. It has been developed and
Fig. 2 Study flowchart. Participant flow through intervention period
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validated for several cohorts of young and/or active
patients with knee injury and/or knee osteoarthritis
[36–39].
Explorative outcome measures
The International Knee Documentation Committee Sub-
jective Knee Form (IKDC) will be used. The IKDC is a
site-specific instrument that has been designed to assess
symptoms, function, and sports activity levels in patients
who have one or more of a variety of knee conditions in-
cluding ligamentous, meniscal, articular cartilage, arth-
ritic and patello-femoral pathologies [38, 40].
The Tegner Activity Score will also be employed, as it
aims to provide a standardized method of grading work
ability of the lower limb, performance of activities of
daily living and magnitude of competitive sport partici-
pation, in patients with orthopedic knee injuries and
knee osteoarthritis. The scale score ranges from 0 (knee-
related sick leave or disability) to 10 (engaged in com-
petitive sports). The Tegner Activity-level Scale has
shown acceptable test-retest reliability in knee patients
[41], and been shown to be valid and reliable for asses-
sing activity level in individuals with ACL injury [38, 41].
Rapid muscle force capacity (rate of force develop-
ment: RFD200), representing the rate of force change
during the very early phase of muscle contraction
(0–200 millisecond (ms) relative to force onset), will
be determined for the knee flexors and extensors
[32, 42, 43].
Three-dimensional kinematic/kinetic analysis of hori-
zontal gait at self-selected velocity and standardized
one- and two-legged (dual-force-plate methodology)
counter-movement jumping (CMJ) will be performed
using an eight-camera motion capture system (100 Hz;
Vicon Motion Systems, Oxford, UK), in synchrony with
two force plates (1000 Hz; AMTI, 0R6-7 Series Inc.,
Watertown, MA, US) embedded in the floor. Bilateral
CMJ will be performed with each leg positioned on a
separate force plate, while unilateral CMJ analysis on a
single force plate will be undertaken in accordance with
the procedures described previously [44]. Using the
standard plug-in-gait marker model and inverse dynam-
ics analysis [44, 45], angle and moments of the lower-
limb joints and be calculated [9, 46].
Postural control is evaluated by assessment of the
movement of the center of pressure (CoP) of the vertical
ground reaction force within the base of support of the
feet to maintain postural equilibrium during the static
stance. Deficits in postural sway have been reported after
ACL injury and reconstruction [29]. Patients will be
instructed to stand one-legged, on the test limb with the
contralateral limb flexed and both arms on the hips and
maintain a stable posture on the platform during which
the range of CoP excursion (30 s) is recorded and
subsequently analyzed [47]. The test will be performed
for both legs, with eyes open and closed.
The one-legged hop for distance mimics ambulant
sporting activities and demands explosive muscle function,
postural balance ability, and functional stability of the
knee. This test has previously been used as a sensitive and
responsive measure in ACL research [9, 48, 49] and previ-
ous studies have reported high test-retest reliability in tri-
als with patients suffering from ACL deficiency [9, 50–52].
The participant stands on the leg to be tested, then
takes off to cover a maximal horizontal distance, and
lands on the same limb with hands placed behind the
back. The participant is carefully instructed to perform a
maximal horizontal hop with a controlled and balanced
landing and to keep the landing foot in place for 2 to
3 s, until the landing position has been recorded by the
tester. Failure to maintain one-legged standing balance
for 3 s results in a disqualified hop. The distance hopped
is measured in centimeters (±0.5 cm) from the toe at
push-off to the heel where the participant lands. Partici-
pants will perform one practice trial and at least three
test trials or until no further improvement is observed.
The best trial will be used, and a symmetry index will be
calculated (reconstructed side/non-affected side).
Tendon regeneration (semitendinosus tendon) and
changes in macroscopic hamstring and quadriceps
muscle morphology (hypertrophy) will be assessed by
MRI. Evaluation will be performed for all participants
from both groups prior to, and after, the 12-week inter-
vention period.
MRI scans will range from the iliac crest orthogonal
axial plane to the transition between the proximal tibial
metaphysis and diaphysis, while participants lie supine
in the scanner (Philips Inginia 1.5 T system with soft-
ware release R5.1.17). MRI sequence details will be the
following: Coil = Integrated posterior/anterior coil; se-
quence, transverse T1-weighted mDIXON TSE, TR
(repetition time) 550 ms; TE (echo time) 20 ms; 1 NSA
(number of signals averaged); FOV (field of view) 340 ×
467 mm., ST (slice thickness) 10 mm; gap 3 mm; num-
ber of slices 60. Post-processed images will be In Phase
(IP) and Water Only (W). Both the radiologist and
primary investigator will, prior to analysis, measure a
subgroup of MRIs to achieve data on inter-observer reli-
ability. All evaluations will be blinded to the participant’s
randomization. In case of disagreement on the radio-
graphic findings, a consensus opinion will be obtained.
All MRI evaluations will be performed in collaboration
with the Section of Musculoskeletal MRI, at the Depart-
ment of Radiology, Odense University Hospital. Ham-
string and quadriceps volume, selected single-site, axial,
cross-sectional area (CSA) values, and hamstring length
will be evaluated by MRI analysis as described by Eriks-
son et al. [20] and Tadokoro et al. [21]. The
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morphological characteristics (volume, peak CSA and
length) of the quadriceps and hamstring muscles will be
evaluated for both limbs using manual segmentation by
tracing the margin of the respective muscle and tendon
in successive axial slices. Furthermore, length of tendon
and muscle will be determined by transversal slice. Mea-
surements will be made of the hamstring muscles, in-
cluding semitendinosus, gracilis, semimembranosus and
the long head of the biceps femoris. Quadriceps muscles
will include rectus femoris, vastus intermedius, lateralis
and medialis. Cross-sectional area will be determined by
locating the 10-mm slice with the greatest CSA and
averaging this along with five additional slices immedi-
ately cranial and caudal (in total, 11 slices). Tendon
regeneration will be defined as having occurred if the
tendon is visible below the musculotendinous junction.
The semitendinosus and gracilis tendons will be identi-
fied, and evaluated in terms of volume, peak CSA and
length, from the distance between the joint line and the
distal muscle-tendon junction. Tendon regeneration will
be evaluated as being full, partial or non-regenerated, in
comparison with the ipsilateral leg [19, 22].
Adverse events
Adverse events will be monitored with a non-leading
questionnaire during the entire phase of intervention, as
a part of participant’s training diary. All events will be
coded in accordance with the Medical Dictionary for
Regulatory Activities, as currently required by all regula-
tory authorities, including the US Food and Drug
Administration and the European Agency for the Evalu-
ation of Medicinal Products. All participants will have
the opportunity to contact the primary investigator (BB)
and the engaged physiotherapist(s) at any time during
the trial. Adverse events or harm to participants during
the intervention will be reported to the primary investi-
gator (BB) daily. There are no stopping criteria based on
the collected data. We intend to report/publish, inde-
pendently of the direction of the results.
Ethical considerations
All participants will be informed about the nature, scope
and risks of the study, and will be asked to give their writ-
ten consent to participate. The trial has been registered
with The Regional Committees on Health Research Ethics
for Southern Denmark with registration ID S-20160034.
The study will be performed in accordance with the
ethical standards in the 1964 Declaration of Helsinki.
Participants may withdraw from the study for any rea-
son at any time. The primary investigator may also with-
draw participants from the study to protect their safety
and/or if they are unwilling or unable to comply with
required study procedures. Throughout the intervention
and follow-up period, participants are reminded, by
email, about consecutive clinical visits. All withdrawals
concerning study participation, will be reported in future
publications, including incomplete outcome datasets,
due to incomplete follow-up, participant discontinue or
deviation from intervention.
No provision of care beyond that immediately required
for the proper and safe conduct of the trial, and the
treatment of immediate adverse events related to trial
procedures is provided. Participants’ healthcare needs
that arise as a direct consequence of trial participation
(e.g., intervention-related harms), will be covered and
treated accordingly, by the Danish public healthcare sys-
tem. No plans are made to provide or pay for ancillary
care during the trial.
All tests described in the protocol have been performed
previously in a similar patient group without causing any
issues and/or undesired side-effects [9]. As described
above, study participants will report pain on a VAS, before
and after each training session. Pain up to 2 on the scale is
considered “safe,” up to 5 is considered “acceptable,” while
pain scores above 5 are considered “high risk.” Post-
training/-testing pain is accepted as long it does not last
for more than 24 h after the previous training/test session
and participants judge the pain to be acceptable.
The study will adhere to Recommendations for the
Conduct, Reporting, Editing and Publication of Scholarly
Work in Medical Journals (the Vancouver Convention)
[53]. The authors of the current protocol article will also
be co-authors on publications derived from this study
relative to their specific contributions. Irrespective of
positive or negative results, the data will be published in
international peer-reviewed journals and presented as
lectures at scientific conferences, nationally and inter-
nationally, in accordance with CONSORT guidelines for
the reporting of clinical trials [23, 24]. The need for a
Data Monitoring Committee (DMC) was deselected due
to known minimal risks of the planned intervention pro-
cedures. Consecutive modifications to trials will be eval-
uated and performed by the Trial Steering Committee
(TSC). Protocol modifications will be reported to, and
approved by, the Steering Committee while also reported
to the Regional Ethical Committee. All modifications
will be communicated to all study members by the pri-
mary investigator (BB) and all modifications to the test
and exercise protocols will be reported at ClinicalTrials.-
gov. No plans are made for ancillary studies involving
the collection or derivation of data for purposes that are
separate from the main trial or for ancillary studies.
Sample size calculation and statistical procedures
Sample size estimation was performed using maximal
unilateral isometric knee-flexor strength of the operated
leg (primary outcome) from a previously published pilot
study on the present test protocol and reliability data
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from our laboratory [5]. The statistical model contains
one baseline and one follow-up assessment.
Between-group difference in change score of 0.31 Nm
bw-1 in knee-flexor strength in the ACL-reconstructed limb
resulting in a less than 2.5% deficit of the healthy leg prior
to intervention is considered of clinical relevance [5]. To
achieve a statistical power of 80% (β = 0.80), using a SD of
0.37 Nm bw-1 pre and post intervention, and allowing the
detection of statistically significant differences at an α =
0.05 level (two-tailed testing), a sample size of n = 23 was
calculated for each group; the estimated recruitment of 50
participants (in total) allows for possible dropouts.
All study data will be obtained electronically on site by
the research physiotherapist in the laboratory where the
data will originate. Original study forms will be col-
lected, stored and entered on file at the participating site
by the research nurse. Participant files are stored in
numerical order in a secure and accessible place. Partici-
pant files will be maintained in storage for a period of
5 years after completion of the study. The research nurse
will, weekly, send email reports with information on
missing data, missing forms and missing visits. A
complete back up of the primary database will be per-
formed twice a month, to an external back-up hard drive
and subsequently to a secure Share-Point location
administrated by the university hospital.
All outcome measures will be checked for Gaussian
distribution by use of QQ-plots and parametric statis-
tical and/or non-parametric analyses will be used when
deemed appropriate. All statistical tests will use an α-
level of 0.05 and data will be presented as means and
95% confidence interval unless otherwise stated.
Between-group mean differences in outcome measures
and 95% confidence intervals will be evaluated using a
general mixed linear model in which the participant’s
baseline score is entered as a covariate [54]. All analyses
will follow the “intention-to-treat principle” [55].
Furthermore, subsequent “per-protocol” analysis for
patients demonstrating the a-priori-defined acceptable
compliance to exercise will be performed. The “last-ob-
servation-carried-forward” method will be used for data
imputation in cases of missing outcome measures. All
statistical analyses will be blinded to the analyst (BB)
and will be performed using Stata 13 software (Stata-
Corp, College Station, TX, USA). No plans for additional
analyses is made.
Data interpretation
To minimize bias, we have a-priori decided how to
interpret different result scenarios: (1) If knee-flexor
strength improvement is superior (statistically significant
and clinically relevant (≥0.31 Nm bw-1 in knee-flexor
strength)) in SNG compared with CON, the combined
intervention of strength and neuromuscular exercises
will be considered the preferred treatment of choice; (2)
If gains in knee-flexor strength are superior in CON
compared with SNG, home-based exercises will be con-
sidered the preferred treatment of choice; and (3) if
knee-flexor strength improvement does not differ
between the two treatment groups, the intervention
associated with the greatest functional improvement and
pain relief, and the least adverse events, will be favored.
Discussion
This randomized clinical trial will evaluate the effect of a
targeted resistance-exercise intervention on neuromus-
cular knee-joint function and muscle-tendon morph-
ology in ACL-reconstructed patients with persistent
hamstring-muscle-strength deficiency. As a prospective
RCT, the results of this study are expected to provide
high-level evidence of the potential clinical and func-
tional benefits of performing an exercise-based interven-
tion in the late rehabilitation phase following ACL
reconstruction, using hamstring auto-grafts. So far, no
RCTs have evaluated the effect of combined,
progressive-resistance training and neuromuscular exer-
cise in the late rehabilitation phase in patients demon-
strating persistent hamstring deficiency following ACL
reconstruction. If deemed effective, the intervention
paradigm introduced in this study may help improve
current treatment strategies for patients undergoing
ACL reconstruction.
Outcome variables
Comprising the primary outcome variable, maximal
hamstring-muscle strength, immediately following inter-
vention (12 weeks) is chosen to examine if persistent
hamstring-strength deficiency can be reduced by targeted
exercise-based intervention. Furthermore, patient-reported
perceived knee-joint function is evaluated at 6-month
follow-up to evaluate the long-term effect of the interven-
tion on knee function and knee-related quality of life.
Patient-reported outcome variables are obtained
(secondary/explorative outcomes) to investigate potential
effects on self-perceived function in daily living, knee
pain, symptoms, sports and recreation and knee-related
quality of life. A recent cross-sectional study from our
laboratory demonstrated strong associations between
patient-reported outcomes and the objective outcomes
listed in the current trial [9]. Such potential associations,
if also detected in the current prospective RCT, may
provide further understanding of the underlying impair-
ments in neuro-mechanical muscle function associated
with ACL surgery.
In accordance with the International Classification of
Function, Disability and Health [56] the current test
battery is composed of different test types that cover dif-
ferent domains. Maximal isometric muscle strength is
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related to body structure and function whereas the
remaining test types (one-legged jump for distance, kine-
matic/kinetic outcomes of gait and counter movement
jumping) mainly serve to evaluate neuromuscular
impairments, which are primarily related to activity.
Impairments in body structure and function (i.e., Max-
imum Voluntary Contraction (MVC)) are linked to limi-
tations in activity [56], which have been proposed to
affect health-related quality of life [57]. Thus, interven-
tion paradigms aimed at improving maximal knee-
extensor and flexor strength (MVC) might be expected
to improve activity outcomes and thereby positively
affect quality of life. In support of this notion, we have
previously demonstrated that hamstring and quadriceps
MVC are central outcome variables to explain the inter-
individual variation in KOOS profile (subjectively per-
ceived knee-joint function) in ACL-reconstructed
patients [9]. Thus, it may be reasonable to assume that
the expected improvements in hamstring and/or
quadriceps-muscle strength elicited by the intervention
regimen will result in improvements in the remaining
three test types evaluating activity and patient-reported
outcomes. The present choice of relevant test parame-
ters is based on previous study reports [9, 31, 48–51,
58–64] and is commonly used in the local department of
orthopedics and orthopedic/biomechanical science.
Study design
To ensure a high internal validity and to avoid subgroup
analysis due to potential differences in rehabilitation
protocol(s), all participants allocated to CON interven-
tion will be advised to perform home-based exercises of
low intensity (for details, see Additional file 3). Conse-
quently, this may affect the generalizability, especially in
the conventional clinical settings where late-phase
(12 months post surgery) rehabilitation generally is not
offered to patients, besides brief recommendations
regarding engaging in training and/or referencing to
web-based rehabilitation programs.
To improve external validity and generalizability, only
a few exclusion criteria will be employed. An exclusion
criterion of BMI above 35 will be used since obesity
causes soft skin tissue artifacts that will affect the valid-
ity of 3-dimensional motion analysis. Mechanical stabil-
ity in the reconstructed knee, will be evaluated by the
surgeon at the standard 1-year outpatient clinic follow-
up. In case of an insufficiently healed graft, poor mech-
anical knee-joint stability or reduced range of motion,
the surgeon will evaluate the need for re-surgery. In
such cases participants will be excluded due to the
potential occurrence of other known joint pathologies
that may affect adherence to the intervention protocol.
Patients who demonstrate associated meniscal and/or
cartilage procedures, which are commonly related to
ACL reconstruction, will not be excluded even though
their functional limitations may be slightly different from
the remaining sample.
Since the trial is based upon patients volunteering for
a physical intervention, the study may potentially be
affected by selection bias. However, it will be possible to
compare the KOOS scores of the current sample with all
patients registered in the Danish National ACL Recon-
struction Registry and consequently assess potential
discrepancies.
Acceptable compliance with exercise will be defined as
participation in 75% or more of all training sessions con-
ducted (i.e., 18 sessions). The current study will be based
upon the “intention-to-treat” analysis including all pa-
tients allocated for training irrespective of the number of
training sessions. A “per-protocol” analysis will also be
performed to explore whether compliance to training
will have any effect on the observed results.
Limitations
Analysis of cost-effectiveness is not planned for this inter-
vention. Furthermore, despite the interesting perspective
of qualitative analysis concerning patient experience that
could have been added to the protocol, no priority on this
perspective has been obtained and is thus omitted.
Due to the non-invasive/non-pharmacological interven-
tion, no auditing is planned during the trial. Due to a rela-
tively low sample-size of the present mechanistic trial no
analysis of cost-effectiveness is planned for this study.
Summary
This study will use a randomized controlled design to
investigate the effect of a targeted exercise intervention
compared with controls, on knee-joint function in
patients with persistent hamstring-muscle-strength defi-
ciency 1 year after ACL reconstruction surgery using
hamstring tendon auto-graft. The trial results should
help to determine whether targeted exercise interven-
tions can increase hamstring strength, and thereby be
employed in the late rehabilitation phase for ACL-
reconstructed patients demonstrating persistent ham-
string muscle-strength deficiency. If deemed effective,
the intervention paradigm introduced in this study may
help to improve current treatment strategies and their
timing for patients undergoing hamstring auto-graft
ACL reconstruction. Furthermore, the explorative part
of the trial will provide understanding of the underlying
impairment in mechanical muscle function associated
with ACL reconstruction. The results will be submitted
to a peer-reviewed international journal for publication
irrespectively of the outcome obtained, in accordance
with the CONSORT guidelines for the reporting of
clinical trials.
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